NCT00486382View on ClinicalTrials.gov

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Visceral LeishmaniasisPost-kala-azar Dermal Leishmaniasis
Interventions
BIOLOGICAL

Leish-111f + MPL-SE Adjuvant

Trial Locations (1)

221 005

Banaras Hindu University, Varanasi

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Access to Advanced Health Institute (AAHI)

OTHER

NCT00486382 - Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India | Biotech Hunter | Biotech Hunter